Brief: Supernus Announces First Quarter 2023 Financial Results
09/05/2023 23:06
Supernus Pharmaceuticals Inc SUPN.O :
* SUPERNUS ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESULTS
* RAISES FULL YEAR 2023 GAAP AND NON-GAAP OPERATING EARNINGS
GUIDANCE
* QTRLY EARNINGS PER SHARE $0.29
* Q1 EARNINGS PER SHARE VIEW $0.17 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX5kzK7M
Further company coverage: SUPN.O
Recent news on Supernus Pharmaceuticals
See all newsHuron Consulting poised to hit fresh record ahead of S&P SmallCap addition
Brief: S&P Dow Jones Indices Msg Rangers And Huron Consulting Group Set To Join S&P Smallcap 600
Brief: Supernus Pharmaceuticals Says FDA Grants Seven Years Orphan-Drug Exclusivity For Onapgo
Supernus Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVE -Micron Technology, Ares Management, Boeing